23.03.2013
- The U.S. Supreme Court will hear arguments on Monday over whether big drug companies can settle patent litigation with generic rivals by making deals to keep cheaper products off...
15.02.2013
- Merck & Co has agreed to pay $688 million to settle two U.S. class-action lawsuits by shareholders who said they lost money because the company concealed the poor results of a...
21.06.2011
- A federal appeals court rejected Merck & Co's bid for a new trial to obtain $472.9 million of federal income tax refunds that the drugmaker believes it deserves. The 3rd U.S...
07.04.2011
- U.S. drugmaker Merck & Co., which last year said it would close three research sites in the Netherlands, on Thursday said it would keep about half of the research and development...
21.01.2011
- Pressures on the U.S. pharmaceutical industry has built over the past few years, stemming from an increasingly stringent drug regulatory environment and the global economic...
02.08.2010
- Chances are, every big pharmaceutical company is running the numbers and weighing the pros and cons of acquiring Genzyme. French drugmaker Sanofi-Aventis is poised to make a bid...
09.07.2010
- Merck & Co announced plans to close eight research sites and eight manufacturing sites as it restructures in the wake of its merger with rival drugmaker Schering-Plough Corp. Merck...
12.05.2010
- Merck & Co plans to seek approval for five new medicines this year, including a closely watched hepatitis C treatment, but has halted development of an experimental anemia medicine...
